Processing the protocol with id 144
##########################################
Searching for the item "2a Scientific background and explanation of rationale..."
This part was defined, probably, at this section: 1. INTRODUCTION 
I have not found anything about the rationales from titles, lets take a look for the introduction
Rationales: NOT FOUND
I have not found anything about the previous studies from titles, lets take a look for the introduction
Previous studies: FOUND
Occurrences in the text:
12388	clinical experience	"... C00014  Date 18 June 2007  Previous clinical experience  1.1.3 Study 4054..."
12455	Phase II 	"... 4054 IL/0006 (D4320 C00006) was a Phase II study in 312 men with..."
13224	Phase II 	"... the  10 mg and 15 mg dose arms in the Phase II study (4054 IL/0006) showed..."
##########################################
Searching for the item "2b Specific objectives or hypotheses"...
This part was defined, probably, at this section: 1.1 The main purpose of this study is to assess the effect of ZD4054 on overall survival compared 
Primary objectives: NOT FOUND
Secondary objectives: NOT FOUND
Objectives: FOUND
Occurrences in the text:
15696	investigate 	"...  to  investigate as yet unidentified serum biomarkers that correlate to parameters such as response  20..."
##########################################
Searching for the item "3a Description of trial design (such as parallel, factorial) including allocation ratio"...
This part was defined, probably, at this section: 3. STUDY PLAN AND PROCEDURES 
I found the following features of the study:
placebo controlled
double blind
randomised
Phase III
placebo  controlled
2 arm
2 different treatment arm
Placebo: found -> randomized-controlled study
Occurrences in the text:
24627	placebo	 "... group, multi centre, 2 arm, placebo controlled  Phase III..."
24733	placebo	 "... ZD4054 in comparison with  placebo in patients with..."
24914	placebo	 "... to either ZD4054 or  placebo. In addition to trial..."
25588	placebo	 "... or having to stop ZD4054 or placebo therapy. Chemotherapy..."
26477	placebo	 "... will receive 10 mg ZD4054 or placebo (see Section 3.4)..."
28934	placebo	 "...  Discontinue  ZD4054/placebo if  applicable. If ..."
35591	placebo	 "... benefit seen in the  placebo controlled Phase II..."
35671	placebo	 "... C00006)). It needs to be placebo  controlled in order..."
38200	placebo	 "... was seen compared with placebo in previous studies,..."
39072	placebo	 "... June 2007  comparison with placebo in large scale Phase..."
Allocation ratio: 1:1, 0:4, 5:4, 0:4, 5:4, 1:1, 0:4, 5:4, 0:4, 5:4, 0:4, 5:4, 0:4, 5:4
##########################################
Checking for the item "4a Eligibility criteria for participants..."
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item "5 Interventions for each group with sufficient details to allow replication, including how and when they were actually administered"
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item “7a how sample size was determined”...
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Searching any information about a randomzation
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
I found information about blocks:
62607	balanced blocks	"... . The patients will be  allocated to treatment in balanced blocks.  . E S U   E R O F E B   Y T I D..."
##########################################
Checking for the item “11a  if done, who was blinded after assignment to interventions (eg, participants, care providers, those assessing outcomes) and how.”
This part was defined, probably, at this section: 3.7.2 Methods for unblinding the study 
This part was defined, probably, at this section: 6.1 A comprehensive Statistical Analysis Plan (SAP) will be finalised before unblinding of the 
##########################################
Checking for the item “12a  statistical methods used to compare groups for primary and secondary outcomes”
This part was defined, probably, at this section: 6. STATISTICAL METHODS AND DETERMINATION OF 
This part was defined, probably, at this section: 6.1 A comprehensive Statistical Analysis Plan (SAP) will be finalised before unblinding of the 
I found the following methods:
149426 	 log rank 	 "... all survival will be analysed using the log rank test. Patients who have not..."
150003 	 log rank 	 "... ree survival will be analysed using the log rank test. Progression is defined..."
150991 	 log rank 	 "... e of opiates will be analysed using the log rank test. Patients who have not..."
151555 	 log rank 	 "... lated events will be analysed using the log rank test. Patients who have not ..."
152131 	 log rank 	 "... bone lesions will be analysed using the log rank test. Patients  who have not..."
153695 	 log rank 	 "...  progression will be analysed using the log rank test. Patients who have not..."
155113 	 log rank 	 "... chemotherapy will be analysed using the log rank test. Patients who have not ..."
160217 	 fleming 	 "... ts have been reached. Using the O Brien Fleming stopping rule, the level of..."
149763 	 kaplan meier 	 "... d on active treatment  than on placebo. Kaplan Meier plots of the times to..."
150406 	 kaplan meier 	 "... r  on active treatment than on placebo. Kaplan Meier plots of the times to..."
151340 	 kaplan meier 	 "... e is longer on  ZD4054 than on placebo. Kaplan Meier plots of the times to..."
151899 	 kaplan meier 	 "... t is longer on ZD4054  than on placebo. Kaplan Meier plots of the times to..."
152476 	 kaplan meier 	 "... t is longer on ZD4054  than on placebo. Kaplan Meier plots of the times to..."
154108 	 kaplan meier 	 "...  95% confidence intervals and p values. Kaplan Meier  plots of the times to PSA..."
155462 	 kaplan meier 	 "... t is longer on ZD4054  than on placebo. Kaplan Meier plots of the times to..."
